News

AFP3d
Merck Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus ...
Merck, a leading science and technology company, today announced positive data on enpatoran, an investigational, oral, novel TLR7/8 inhibitor, demonstrating clinically meaningful reduction in ...
The Motley Fool6d
Earnings Call Transcripts - The Motley Fool
Wiley (WLY) Q4 2025 Earnings Call Transcript. Jun 17, 2025 by Motley Fool Transcribing. Jabil (JBL) Q3 2025 Earnings Call Transcript. Jun 17, 2025 ...